{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T23:04:42Z","timestamp":1775171082295,"version":"3.50.1"},"reference-count":35,"publisher":"Pacini Editore","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Otorhinolaryngol Ital"],"DOI":"10.14639\/0392-100x-n0716","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T12:45:18Z","timestamp":1612874718000},"page":"435-443","source":"Crossref","is-referenced-by-count":12,"title":["Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients","L\u2019efficacia delle terapie biologiche sulla rinosinusite cronica nel paziente asmatico severo"],"prefix":"10.14639","volume":"40","author":[{"given":"Francesco","family":"Bandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Preti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Mozzanica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Visca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Marelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Maddalone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Gambarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano","family":"Vaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Spanevello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Castelnuovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"20340","published-online":{"date-parts":[[2020,12]]},"reference":[{"key":"10.14639\/0392-100X-N0716_ref1","doi-asserted-by":"crossref","unstructured":"Schleimer RP. Immunopathogenesis of chronic rhinosinusitis and nasal polyposis. Annu Rev Pathol 2017;12:331-57. https:\/\/doi.org\/10.1146\/annurev-pathol-052016-100401","DOI":"10.1146\/annurev-pathol-052016-100401"},{"key":"10.14639\/0392-100X-N0716_ref2","unstructured":"Cao PP, Wang ZC, Schleimer RP, et al. Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes. Ann Allergy Asthma Immunol 2019;122:33-40. https:\/\/doi.org\/10.1016\/j.anai.2018.10.01"},{"key":"10.14639\/0392-100X-N0716_ref3","unstructured":"Krouse JH, Krouse HJ. Asthma, rhinitis, and the unified airway. ORL Head Neck Nurs 2013;31:6-10."},{"key":"10.14639\/0392-100X-N0716_ref4","doi-asserted-by":"crossref","unstructured":"van der Veen J, Seys SF, Timmermans M, et al. Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre. Allergy 2017;72:282-90.https:\/\/doi.org\/10.1111\/all.12983","DOI":"10.1111\/all.12983"},{"key":"10.14639\/0392-100X-N0716_ref5","doi-asserted-by":"crossref","unstructured":"Calus L, Van Bruaene N, Bosteels C, et al. Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis. Clin Transl Allergy 2019;9:30. https:\/\/doi.org\/10.1186\/s13601-019-0269-4","DOI":"10.1186\/s13601-019-0269-4"},{"key":"10.14639\/0392-100X-N0716_ref6","doi-asserted-by":"crossref","unstructured":"Edris A, De Feyter S, Maes T, et al. Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis. Respir Res 2019;20:179. https:\/\/doi.org\/10.1186\/s12931-019-1138-3","DOI":"10.1186\/s12931-019-1138-3"},{"key":"10.14639\/0392-100X-N0716_ref7","doi-asserted-by":"crossref","unstructured":"Ren L, Zhang N, Zhang L, et al. Biologics for the treatment of chronic rhinosinusitis with nasal polyps - state of the art. World Allergy Organ J 2019;12:100050. https:\/\/doi.org\/10.1016\/j.waojou.2019.100050","DOI":"10.1016\/j.waojou.2019.100050"},{"key":"10.14639\/0392-100X-N0716_ref8","doi-asserted-by":"crossref","unstructured":"Kartush AG, Schumacher JK, Shah R, et al. Biologic agents for the treatment of chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy 2019;33:203-11. https:\/\/doi.org\/10.1177\/1945892418814768","DOI":"10.1177\/1945892418814768"},{"key":"10.14639\/0392-100X-N0716_ref9","doi-asserted-by":"crossref","unstructured":"Pinto JM, Mehta N, Di Tineo M, et al. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology 2010;48:318-24. https:\/\/doi.org\/10.4193\/Rhin09.144","DOI":"10.4193\/Rhin09.144"},{"key":"10.14639\/0392-100X-N0716_ref10","doi-asserted-by":"crossref","unstructured":"Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 2011;128:989-95.e1-8. https:\/\/doi.org\/10.1016\/j.jaci.2011.07.056","DOI":"10.1016\/j.jaci.2011.07.056"},{"key":"10.14639\/0392-100X-N0716_ref11","doi-asserted-by":"crossref","unstructured":"Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 2013;131:110-6.e1. https:\/\/doi.org\/10.1016\/j.jaci.2012.07.047","DOI":"10.1016\/j.jaci.2012.07.047"},{"key":"10.14639\/0392-100X-N0716_ref12","doi-asserted-by":"crossref","unstructured":"Bachert C, Sousa AR, Lund VJ, et al. Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial. J Allergy Clin Immunol 2017;140:1024-31.e14. https:\/\/doi.org\/10.1016\/j.jaci.2017.05.044","DOI":"10.1016\/j.jaci.2017.05.044"},{"key":"10.14639\/0392-100X-N0716_ref13","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. 2017. Available from: www.ginasthma.org"},{"key":"10.14639\/0392-100X-N0716_ref14","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. 2018. Available from: www.ginasthma.org"},{"key":"10.14639\/0392-100X-N0716_ref15","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. 2019. Available from: www.ginasthma.org"},{"key":"10.14639\/0392-100X-N0716_ref16","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. 2020. Available from: www.ginasthma.org"},{"key":"10.14639\/0392-100X-N0716_ref17","doi-asserted-by":"crossref","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 2020;58(Suppl S29):1-464. https:\/\/doi.org\/10.4193\/Rhin20.600","DOI":"10.4193\/Rhin20.600"},{"key":"10.14639\/0392-100X-N0716_ref18","unstructured":"Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl 2012;23:1-298."},{"key":"10.14639\/0392-100X-N0716_ref19","doi-asserted-by":"crossref","unstructured":"Castelnuovo P, Bandi F, Preti, et al. Implementing strategies for data collection in chronic rhinosinusitis. Acta Otorhinolaryngol Ital 2018;38:222-4. https:\/\/doi.org\/10.14639\/0392-100X-1993","DOI":"10.14639\/0392-100X-1993"},{"key":"10.14639\/0392-100X-N0716_ref20","unstructured":"Akdis CA, Hellings, PW, Agache I; European Academy of Allergy and Clinical Immunology, Editors. Global atlas of allergic rhinitis and chronic rhinosinusitis. Zurich, Switzerland: European Academy of Allergy and Clinical Immunology; 2015."},{"key":"10.14639\/0392-100X-N0716_ref21","doi-asserted-by":"crossref","unstructured":"Mozzanica F, Preti A, Gera R, et al. Cross-cultural adaptation and validation of the SNOT-22 into Italian. Eur Arch Otorhinolaryngol 2017;274:887-95. https:\/\/doi.org\/10.1007\/s00405-016-4313-x","DOI":"10.1007\/s00405-016-4313-x"},{"key":"10.14639\/0392-100X-N0716_ref22","doi-asserted-by":"crossref","unstructured":"Gallo S, Russo F, Mozzanica F, et al. Prognostic value of the Sinonasal Outcome Test 22 (SNOT-22) in chronic rhinosinusitis. Acta Otorhinolaryngol Ital 2020;40:113-21. https:\/\/doi.org\/10.14639\/0392-100X-N0364","DOI":"10.14639\/0392-100X-N0364"},{"key":"10.14639\/0392-100X-N0716_ref23","doi-asserted-by":"crossref","unstructured":"Gelardi M, Piccininni K, Quaranta N, et al. Olfactory dysfunction in patients with chronic rhinosinusitis with nasal polyps is associated with clinical-cytological grading severity. Acta Otorhinolaryngol Ital 2019;39:329-35. https:\/\/doi.org\/10.14639\/0392-100X-2426","DOI":"10.14639\/0392-100X-2426"},{"key":"10.14639\/0392-100X-N0716_ref24","doi-asserted-by":"crossref","unstructured":"Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 1997;117(3 Pt 2):S35-40. https:\/\/doi.org\/10.1016\/s0194-5998(97)70005-6","DOI":"10.1016\/S0194-5998(97)70005-6"},{"key":"10.14639\/0392-100X-N0716_ref25","doi-asserted-by":"crossref","unstructured":"Meltzer EO, Hamilos DL, Hadley JA. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol 2006;118(5 Suppl):S17-61. https:\/\/doi.org\/10.1016\/j.jaci.2006.09.005","DOI":"10.1016\/j.jaci.2006.09.005"},{"key":"10.14639\/0392-100X-N0716_ref26","doi-asserted-by":"crossref","unstructured":"Bidder T, Sahota J, Rennie C, et al. Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study. Rhinology 2018;56:42-5. https:\/\/doi.org\/10.4193\/Rhin17.139","DOI":"10.4193\/Rhin17.139"},{"key":"10.14639\/0392-100X-N0716_ref27","doi-asserted-by":"crossref","unstructured":"Numata T, Nakayama K, Utsumi H, et al. Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis. BMC Pulm Med 2019;19:176. https:\/\/doi.org\/10.1186\/s12890-019-0952-1","DOI":"10.1186\/s12890-019-0952-1"},{"key":"10.14639\/0392-100X-N0716_ref28","doi-asserted-by":"crossref","unstructured":"Tsurumaki H, Matsuyama T, Ezawa K, et al. Rapid effect of benralizumab for hypereosinophilia in a case of severe asthma with eosinophilic chronic rhinosinusitis. Medicina (Kaunas) 2019;55:336. https:\/\/doi.org\/10.3390\/medicina55070336","DOI":"10.3390\/medicina55070336"},{"key":"10.14639\/0392-100X-N0716_ref29","doi-asserted-by":"crossref","unstructured":"Rowan NR, Naclerio RM. Persistence of sinonasal disease despite mepolizumab. J Allergy Clin Immunol Pract 2020;8:1550-5. https:\/\/doi.org\/10.1016\/j.jaip.2020.01.049","DOI":"10.1016\/j.jaip.2020.01.049"},{"key":"10.14639\/0392-100X-N0716_ref30","unstructured":"Jandus P, Harr T, Soyka MB, et al. Efficacit\u00e9 de l\u2019omalizumab dans la polypose nasale: \u00e0 propos de deux cas [The efficacy of omalizumab in the treatment of chronic rhinosinusitis with nasal polyps: a discussion of 2 refractory cases]. Rev Med Suisse 2019;15:1748-51."},{"key":"10.14639\/0392-100X-N0716_ref31","doi-asserted-by":"crossref","unstructured":"Zarbin M. Real life outcomes vs. clinical trial results. J Ophthalmic Vis Res 2019;14:88-92. https:\/\/doi.org\/10.4103\/jovr.jovr_279_18","DOI":"10.4103\/jovr.jovr_279_18"},{"key":"10.14639\/0392-100X-N0716_ref32","doi-asserted-by":"crossref","unstructured":"Shay AD, Tajudeen BA. Histopathologic analysis in the diagnosis and management of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2019;27:20-4. https:\/\/doi.org\/10.1097\/MOO.0000000000000510","DOI":"10.1097\/MOO.0000000000000510"},{"key":"10.14639\/0392-100X-N0716_ref33","doi-asserted-by":"crossref","unstructured":"Huang CC, Chang PH, Wu PW, et al. Impact of nasal symptoms on the evaluation of asthma control. Medicine (Baltimore) 2017;96:e6147. https:\/\/doi.org\/10.1097\/MD.0000000000006147","DOI":"10.1097\/MD.0000000000006147"},{"key":"10.14639\/0392-100X-N0716_ref34","doi-asserted-by":"crossref","unstructured":"Chan R, RuiWen Kuo C, Lipworth B. Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 2020;8:1714-6. https:\/\/doi.org\/10.1016\/j.jaip.2020.01.009","DOI":"10.1016\/j.jaip.2020.01.009"},{"key":"10.14639\/0392-100X-N0716_ref35","doi-asserted-by":"crossref","unstructured":"Delemarre T, Holtappels G, De Ruyck N, et al. Type 2 inflammation in chronic rhinosinusitis without nasal polyps: another relevant endotype. J Allergy Clin Immunol 2020;146:337-43.e6. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.040","DOI":"10.1016\/j.jaci.2020.04.040"}],"container-title":["Acta Otorhinolaryngologica Italica"],"original-title":[],"link":[{"URL":"https:\/\/www.actaitalica.it\/article\/view\/716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T07:16:53Z","timestamp":1729667813000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.actaitalica.it\/article\/view\/716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,12]]}},"URL":"https:\/\/doi.org\/10.14639\/0392-100x-n0716","relation":{},"ISSN":["1827-675X"],"issn-type":[{"value":"1827-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"article-number":"7"}}